Clinical proteomics in neurodegenerative disorders

H Zetterberg, U Rüetschi, E Portelius… - Acta Neurologica …, 2008 - Wiley Online Library
Neurodegenerative disorders are characterized by neuronal impairment that eventually
leads to neuronal death. In spite of the brain's known capacity for regeneration, lost neurons …

Clinical proteomics in neurodegenerative disorders.

H Zetterberg, U Rüetschi, E Portelius… - Acta Neurologica …, 2008 - search.ebscohost.com
Neurodegenerative disorders are characterized by neuronal impairment that eventually
leads to neuronal death. In spite of the brain's known capacity for regeneration, lost neurons …

[引用][C] Clinical proteomics in neurodegenerative disorders

H ZETTERBERG, U RÜETSCHI… - Acta neurologica …, 2008 - pascal-francis.inist.fr
Clinical proteomics in neurodegenerative disorders CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …

Clinical proteomics in neurodegenerative disorders

H Zetterberg, U Ruetschi, E Portelius… - Acta Neurologica …, 2008 - hero.epa.gov
Neurodegenerative disorders are characterized by neuronal impairment that eventually
leads to neuronal death. In spite of the brain's known capacity for regeneration, lost neurons …

Clinical proteomics in neurodegenerative disorders

H Zetterberg, U Rüetschi, E Portelius… - Acta neurologica …, 2008 - pubmed.ncbi.nlm.nih.gov
Neurodegenerative disorders are characterized by neuronal impairment that eventually
leads to neuronal death. In spite of the brain's known capacity for regeneration, lost neurons …